PMA device
CP Stent (Model 425)
NuMED, Inc. · Aortic Stent (PNF, Class III) · First FDA decision Jul 6, 2026, newest Jul 6, 2026Congenital heart disease
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
PMA pathway
Device trials
136
Naming "CP"
MAUDE reports
23,477
Brand "CP", since 2015
PubMed studies
97,155
Mentioning "CP"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing CP Stent (Model 425)
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- CP Stent (Model 425), Covered CP Stent (Model 427), Mounted CP Stent (Model 426), Covered and Mounted CP Stent (Model 42PMA supplement
P150028-S007 · Decided Jul 6, 2026 · 350 days after receipt · Normal 180 Day Track
Device type: Aortic stent (PNF) · Cardiology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Extracorporeal Photopheresis (ECP)National analysisReview closedCAG-00324R2Updated Sep 17, 2026
- External Counterpulsation (ECP) TherapyNational analysisReview closedCAG-00002R2Updated Sep 17, 2026
- Continuous Positive Airway Pressure (CPAP) Therapy for Obstructive Sleep Apnea (OSA)National analysisReview closedCAG-00093R2Updated Sep 17, 2026
- Continuous Positive Airway Pressure (CPAP) Therapy for Obstructive Sleep Apnea (OSA)National analysisReview closedCAG-00093RUpdated Sep 17, 2026
- Continuous Positive Airway Pressure (CPAP) Therapy for Obstructive Sleep Apnea (OSA)National analysisReview closedCAG-00093NUpdated Sep 15, 2026
- Glycated Hemoglobin/Glycated Protein (Addition of CPT Code 83037, Hemoglobin; glycosylated [A1c] by device cleared by FDA for home use)Coding analysisReview closedCAG-00373NUpdated Sep 14, 2026
- External Counterpulsation (ECP) TherapyNational analysisReview closedCAG-00002RUpdated Sep 14, 2026
- External Counterpulsation (ECP) TherapyNational analysisReview closedCAG-00002NUpdated Sep 14, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "CP", any status and sponsor, newest update first.
- Pivotal Study of the SUpira System in Patients Undergoing High-Risk Percutaneous COronaRy InTervention (HRPCI)Pivotal-lookingRecruiting
Supira MedicalNot on our public-company list
NCT07296744 · 358 participants (planned) · Start May 11, 2026 · Primary completion Nov 2027
Device: The Supira System; Impella · For: Coronary Artery Disease; High Risk Percutaneous Coronary Intervention; Interventional Cardiology and 1 more
Sites: Loma Linda, California; Sacramento, California; Thousand Oaks, California · 27 sites in all
University Hospital of CologneAcademic, hospital or other
NCT07655479 · 115 participants (planned) · Start Apr 23, 2026 · Primary completion Oct 2028
Device: Escalation to more capable microaxial flow-pump (Impella 5.5) · For: Cardiogenic Shock Post Myocardial Infarction
Sites: Düsseldorf, Germany; Kiel, Germany; Cologne, Germany
Reem AlharthiAcademic, hospital or other
NCT05352607 · 23 participants · Start Feb 9, 2022 · Primary completion Apr 9, 2022
Device: Transcutaneous Electrical Nerve Stimulation (TENS) · For: Cerebral Palsy
Sites: Ta'if, Saudi Arabia
133 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "CP", and for the whole product code for context.
This brand
23,477 reports: 7,312 malfunction, 13,417 injury, 2,742 death
Whole product code PNF
92 reports: 73 malfunction, 18 injury, 1 death
Newest reports for this brand
- Impella CPMalfunction
1220648-2026-14129 · Received Oct 30, 2026 · Event dated Oct 7, 2026
Device type: Temporary Non-Roller Type Left Heart Support Blood Pump (OZD)
Device problem as coded: Component Missing
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
1220246-2026-05419 · Received Oct 27, 2026 · Event dated Jun 20, 2024
Device type: Fastener, Fixation, Nondegradable, Soft Tissue (MBI)
Device problem as coded: Break
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- Impella CPInjury
1220648-2026-13912 · Received Oct 26, 2026 · Event dated Oct 2, 2026
Device type: Temporary Non-Roller Type Left Heart Support Blood Pump (OZD)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Hemolysis
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "CP"[tiab]. The summary above synthesizes these.
- Clinical characteristics of smoking-related chronic pancreatitis.
Hao L, Liu Y, Dong ZQ, et al. · Front Cell Infect Microbiol · 2022Research Support, Non-U.S. Gov't
- Cerebral palsy registries.
Cans C, Surman G, McManus V, et al. · Semin Pediatr Neurol · 2004Research Support, Non-U.S. Gov't, Review
- The Capsular Polysaccharide Obstructs Wall Teichoic Acid Functions in Staphylococcus aureus.
Lehmann E, van Dalen R, Gritsch L, et al. · J Infect Dis · 2024Research Support, Non-U.S. Gov't
- Causative factors in cerebral palsy.
Nelson KB · Clin Obstet Gynecol · 2008Research Support, N.I.H., Intramural, Review
- Compartmentalized pressurization is a novel prognostic factor for hypercontractile esophagus.
Leopold AR, McCarthy P, Nair A, et al. · Neurogastroenterol Motil · 2024Research Support, N.I.H., Extramural
- Mechanism of actin capping protein recruitment and turnover during clathrin-mediated endocytosis.
Lamb AK, Fernandez AN, Eadaim A, et al. · J Cell Biol · 2024Research Support, U.S. Gov't, Non-P.H.S.
- Which is the Most Common Physiologic Type of Cerebral Palsy?
Kamate M, Detroja M · Neurol India · 2022
- Dysarthria syndromes in children with cerebral palsy.
Schölderle T, Haas E, Ziegler W · Dev Med Child Neurol · 2021Research Support, Non-U.S. Gov't
- Insights From Genetic Studies of Cerebral Palsy.
Lewis SA, Shetty S, Wilson BA, et al. · Front Neurol · 2020Review
- Genetic Risk Factors in Early-Onset Nonalcoholic Chronic Pancreatitis: An Update.
Wertheim-Tysarowska K, Oracz G, Rygiel AM · Genes (Basel) · 2021Research Support, Non-U.S. Gov't, Review
- Epidemiological Characteristics of Carbapenemase Producing Carbapenem-Resistant Enterobacteriaceae Colonization.
Jeong IS, Song JY · Asian Nurs Res (Korean Soc Nurs Sci) · 2022
- Electroacupuncture activates the peroxisome proliferators-activated receptor pathway to improve the phenotype of cerebral palsy.
Wu ZF, Peng HH, Shu Y, et al. · CNS Neurosci Ther · 2024Research Support, Non-U.S. Gov't
Other devices of this type
Also filed under product code PNF.
- Minima Stent SystemRenata Medical, Inc. · PMA 2026
- Cheatham Platinum (CP) Stent System (Covered CP StentNuMED, Inc. · PMA 2017
- Minima Pro Stent SystemRenata Medical, Inc. · PMA 2026
- G-Armor StentNuMED, Inc. · PMA 2021
- NuDel Delivery SystemNuMED, Inc. · PMA 2018
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.